Advances in Atherothrombotic Diseases

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 1009

Special Issue Editor


E-Mail Website
Guest Editor
Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
Interests: platelets; atherosclerosis; cardiovascular diseases; thrombosis; metabolic syndrome; diabetes; hypercholesterolemia; vascular smooth muscle cells; coagulation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Atherothrombosis is one of the major causes of morbidity and mortality in the occidental world. Cardiovascular risk factors such as hypertension, insulin resistance, type 2 diabetes, dyslipidemia, smoking, obesity, sedentary life, oxidative stress, and genetic factors induce the formation of atherosclerotic plaques in the lumen of medium and large arteries like the carotids and aorta, as well as the coronary and peripheral arteries of the lower limbs. Several cells are involved in atherogenesis, including endothelial cells, vascular smooth muscle cells, monocytes/macrophages, lymphocytes, and platelets. Plaque rupture causes the release of many proinflammatory cells and mediators, the partial reduction in blood flow, or obstruction, which is why the process of atherosclerosis plays a crucial role in the development of cardiovascular and cerebrovascular diseases such as acute myocardial infarction, heart failure, angina pectoris, transient ischemic attack, stroke, and claudicatio intermittens.

This Special Issue will therefore welcome original articles and reviews that focus on atherothrombosis, and the cellular and molecular pathways involved in its development. Studies that assess the effects of current therapies to prevent atherothrombosis and to protect patients from the development of cardio- and cerebrovascular events will also be welcomed.

Dr. Cristina Barale
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atherothrombosis
  • cardiovascular risk factors
  • atherosclerosis
  • endothelial cells
  • vascular smooth muscle cells
  • platelets
  • cardiovascular events

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 465 KiB  
Article
Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
by Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel and Filiz Mercantepe
Biomedicines 2024, 12(8), 1862; https://doi.org/10.3390/biomedicines12081862 - 15 Aug 2024
Viewed by 721
Abstract
Background: Subacute thyroiditis (SAT) is characterized by profound inflammation and fluctuations in thyroid hormones which may affect the hemostasis balance. This study investigates sex-specific associations between thyroid status, inflammation and hemostasis biomarkers in SAT. Methods: We included 52 patients (40 women [...] Read more.
Background: Subacute thyroiditis (SAT) is characterized by profound inflammation and fluctuations in thyroid hormones which may affect the hemostasis balance. This study investigates sex-specific associations between thyroid status, inflammation and hemostasis biomarkers in SAT. Methods: We included 52 patients (40 women and 12 men) treated with non-steroidal anti-inflammatory drugs (NSAID) or methylprednisolone (MPS). Free thyroxine (fT4), thyroid stimulating hormone, C-reactive protein, complete blood count and routine hemostasis parameters were assessed. Results: Both men and women were in hyperthyroid state and had comparable levels of inflammatory biomarkers. A shortened activated partial thromboplastin time (aPTT) was observed in 16.7% of the men and 10% of the women (p = 0.562), and a shortened prothrombin time (PT) was observed in 33% of the men and 12.5% of the women (p = 0.094). In men, aPTT positively correlated with fT4 (r = 0.627; p < 0.05), while PT positively correlated with leukocyte-based inflammatory indices in women (p < 0.05). NSAID-treated patients had lower aPTTs and platelet counts than those treated with MPS (p < 0.05). Principal component analysis extracted “proinflammatory”, “prothrombotic” and “antithrombotic” factors, but the “proinflammatory” factor was the independent predictor of elevated fT4 in women (OR = 2.705; p = 0.036). Conclusions: Our data demonstrated sex-specific associations of thyroid status and inflammatory biomarkers with hemostasis parameters in SAT. Routine hemostasis screening tests may help in monitoring the changes in the hemostasis system over the course of SAT. Full article
(This article belongs to the Special Issue Advances in Atherothrombotic Diseases)
Show Figures

Figure 1

Back to TopTop